Inappropriate use of emergency department resources in Iran is a frequent problem that calls for effective approaches and interventions.
2018 was a landmark year for new drug approvals. However, patients’ access to these novel drugs varied by drug category and enrolled health plan.
The US Food and Drug Administration granted emergency use authorization of intravenous neuraminidase inhibitors for patients with 2009 influenza A (H1N1), creating a need for economic studies.
More comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.
This decision tree model estimates the cost per response and incremental cost per additional responder for romiplostim, eltrombopag, and “watch and rescue” for immune thrombocytopenia.
The Michigan Primary Care Transformation project generated cost savings among adults in Medicaid managed care, particularly high-risk adults, while largely maintaining quality of care.
A chronic disease management company presents promising preliminary results from their remote intensive behavioral counseling intervention, aimed at addressing type 2 diabetes.
Lifting section 1834(m) restrictions on telehealth services would help ACOs to utilize this beneficial tool to achieve their cost, quality, access, and patient engagement goals.
This review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.
Out-of-pocket payments differ widely among oral oncolytic options. As cost for therapy becomes a greater part of treatment decisions, an understanding of patient out-of-pocket cost will be critical in informing choices.
We determine a specialist physician phenotype responsive to financial incentives that may be leveraged to identify physicians and markets well-suited for participation in alternative payment models.
Healthcare forecasting could facilitate personalized insurance benefit design and clinical decision support systems, although increased socioeconomic disparities could result from selective disease management programs.
Physicians recognized as high quality by Bridges to Excellence performed better than their peers on claimsbased quality measures and, in some cases, on resource use measures.
Examining the financial impact that patient assistance programs and the 340B Drug Pricing Program have on improving medication cost.
Current interventions to improve medication adherence lack a clear, uniform approach by which patient compliance can be universally improved.
Two case reports are presented in which previous photographs of the patients appearing in their medical record were of considerable assistance in making the diagnosis.
Perceived barriers and benefits to implementing disease management programs among Israeli healthcare leaders could assist other countries faced with increasing numbers of chronically ill patients.
Findings from TRICARE's disease management programs for asthma, congestive heart failure, and diabetes patients suggest that the programs more than pay for themselves.
In an integrated health system, human immunodeficiency virus and hepatitis C telemedicine clinics are associated with improved access, high patient satisfaction, and reduction in health visit“related time.